Bachem to make API for Alzheimer's effort; FDA looks at pre-filled needleless glass syringes;

> Swiss chemical company Bachem will manufacture an investigational API for Slovakian biotechnology firm Axon Neuroscience for its work on Alzheimer's drugs. Item

> Aragen Bioscience and Innovent Biologics have a deal for Aragen to develop manufacturing CHO cell lines for Innovent. Release

> The owner of Pallimed Solutions, which recalled its sterile injectable drugs following an inspection by the FDA, told state regulators the compounding pharmacy may give up making sterile injectables. Story

> India's Dr. Reddy's Laboratories has gotten FDA approval to sell a generic version of the injected osteoporosis drug Reclast. Item

> The FDA is asking for manufacturers and health professionals to comment on draft guidance on how pre-filled needleless glass syringes should work after hearing complaints related to their use with the cardiac drug Adenosine. FDA notice

And Finally... A Dutch pension fund claims it has a commitment from Hospira ($HSP) to make an effort to keep its anesthetic propofol from being sold for U.S. executions. Story